“PD”

“PD-1”

“PD-L1”

“PD-L2”

“pharmacodynamics”

GLOSSARY

progressive disease

programmed cell death protein 1

PD-1 ligand 1, the principal ligand of PD-1.

PD-1 ligand 2, a cell surface protein expressed by
activated macrophages and dendritic cells that binds
PD-1 on T cells to inhibit immune responses

the study of the biochemical and physiologic effects of
drugs (especially pharmaceutical drugs). The effects can
include those manifested within animals
(including
humans), microorganisms, or combinations of organisms
(for example, infection)

“pharmacokinetics” or “PK”

a branch of pharmacology dedicated to determining the
fate of substances administered to a living organism

“PI”

“placebo”

“plasma cells”

Principal investigators

a substance or treatment with no active therapeutic effect,
commonly used in clinical
trials as the administered
substance for the control group

also called plasma B cells, plasmocytes, plasmacytes, or
effector B cells, are white blood cells that secrete large
volumes of antibodies. They are transported by the blood
plasma and the lymphatic system

“plasmablasts”

immature plasma cells

“pneumonia”

“PR”

“proteins”

“proteinuria”

an inflammatory condition of the lung affecting primarily
the small air sacs known as alveoli

partial response

large biological molecules or macromolecules, consisting
of one or more long chains of amino acid residues

the presence of excess proteins in the urine, which is
suggestive of illness

– 43 –

